{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigkfasgfgg5qhtf67nrpv2guqoixhtq3ftbiprggijwptggn3ymj4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mf3lagdyv4g2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicl2ylh346eazb2eajjh7urfmdczgz4wzkise4s7h3igg67u3v5t4"
    },
    "mimeType": "image/jpeg",
    "size": 67130
  },
  "path": "/news/2026-02-immunotherapy-chemotherapy-surgery-pancreatic-cancer.html",
  "publishedAt": "2026-02-17T16:40:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Oncology & Cancer"
  ],
  "textContent": "A new UCLA investigator-initiated study has found that adding immunotherapy to standard chemotherapy before surgery is safe and shows promise for some patients with borderline-resectable pancreatic cancer, a disease that has historically been difficult to treat.",
  "title": "Immunotherapy plus chemotherapy before surgery shows promise for pancreatic cancer"
}